Our Perspectives
THREAD Blog
Factors Shaping Study Timelines: Screenshots, Localized Content, and the Complex Role of IRB Submission Timing
Imagine a time when Sponsors and CROS can manage the study submission process without any dependencies on external parties. Having part of a process dependent on external parties adds risk and undue pressure on all parties and ultimately impacts patients who are waiting for the treatments that are to be tested.
Unlocking the Patient’s Voice – The Benefits of Patient Co-Creation in Clinical Research
While it may seem simple and obvious, one answer to making research work better for patients is through listening to them. This goes beyond simply asking them questions and recording responses (passive listening), but engaging in mindful and intentional active listening, often aided by technology, to capture insights that can lead directly to solutions that improve how clinical studies work.
Three Tips for Successful eCOA in Global, Decentralized Oncology Trials
The idea behind implementing decentralized clinical trial (DCT) approaches in oncology trials is to improve the participant experience. While participants may still need to visit clinics to receive infusion medications in most oncology studies, DCT elements can ease their trial burden by collecting data remotely in between visits. A key component of this strategy is the effective use of electronic clinical outcome assessments (eCOA).
Addressing the slow adoption of decentralized clinical trials (DCTs)
Decentralized approaches provide a more patient-centric strategy, and many industry leaders and subject experts want to move forward with the technology, however, this transition results in extra challenges and questions when it comes to the those examining the operations, protocol design or feasibility of a study…